Nonetheless, the ketogenic diet has been shown to limit cancer growth in many preclinical models via lowering of insulin and IGF-1, and intriguingly has shown synergy in combination with cancer therapies that disrupt the insulin/IGF-1/PI3K axis in host organs (120). Here, IGF1 is linked to cancer.